Premium
Transplacental Flecainide Therapy for Fetal Supraventricular Tachycardia in a Twin Pregnancy
Author(s) -
Edwards Andrew,
Peek Michael J.,
Curren Jan
Publication year - 1999
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.1999.tb03458.x
Subject(s) - flecainide , transplacental , supraventricular tachycardia , medicine , fetus , pregnancy , gestation , twin pregnancy , obstetrics , tachycardia , anesthesia , placenta , atrial fibrillation , biology , genetics
Summary: We present the case of a twin pregnancy in which 1 fetus developed hydrops secondary to supraventricular tachycardia at 30 weeks' gestation. Transplacental flecainide administration successfully treated the condition without evidence of maternal or fetal side‐effects. The case raises ethical and possibly legal issues that present when 1 fetus in a twin pregnancy develops a condition the management of which could cause complications to the other twin and/or the mother.